BMI is an important determinant of VWF and FVIII levels and bleeding phenotype in patients with von Willebrand disease

Ferdows Atiq, Karin Fijnvandraat, Karin P. M. van Galen, B. A. P. Laros-van Gorkom, Karina Meijer, J. de Meris, Michiel Coppens, E. P. Mauser-Bunschoten, M. H. Cnossen, J. G. van der Bom, Jeroen Eikenboom, F. W. G. Leebeek*, K. Fijnvandraat, M. Coppens, A. Kors, S. Zweegman, G. J. Goverde, M. H. Jonkers, N. Dors, M. R. NijzielL. Nieuwenhuizen, K. Meijer, R. Y. J. Tamminga, P. W. van der Linden, P. F. Ypma, H. C. J. Eikenboom, F. J. W. Smiers, B. Granzen, K. Hamulyak, P. Brons, F. Atiq, K. P. M. van Galen, “Willebrand in the Netherlands Study” (WiN study) Group

*Corresponding author for this work

Research output: Contribution to journalComment/Letter to the editorAcademicpeer-review

Original languageEnglish
Pages (from-to)E201-E205
Number of pages6
JournalAmerican Journal of Hematology
Volume94
Issue number8
DOIs
Publication statusPublished - Aug 2019

Cite this